Angiotensin receptor-neprilysin inhibition in heart failure with preserved ejection fraction: lessons from PARAGON-HF

Eur J Heart Fail. 2020 Sep;22(9):1525-1530. doi: 10.1002/ejhf.1976. Epub 2020 Aug 28.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminobutyrates / therapeutic use
  • Angiotensin Receptor Antagonists / therapeutic use
  • Angiotensins
  • Drug Combinations
  • Heart Failure* / drug therapy
  • Humans
  • Neprilysin
  • Receptors, Angiotensin
  • Stroke Volume
  • Tetrazoles / therapeutic use

Substances

  • Aminobutyrates
  • Angiotensin Receptor Antagonists
  • Angiotensins
  • Drug Combinations
  • Receptors, Angiotensin
  • Tetrazoles
  • Neprilysin